Clinical Trial Update: Safety Study of Photodynamic Therapy Using Photocyanine Injection in Treating Patients With Malignant Tumors [Phase 1]

View source ↗

Summary

Phase 1 safety study of Photodynamic Therapy using Photocyanine injection in patients with malignant tumors, including skin cancer and esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Skin Cancer

Drugs mentioned

• Photocyanine

Snippet

Sponsor: Fujian Longhua Pharmaceutical Co. Ltd | Conditions: Skin Cancer, Esophageal Cancer | Phase 1 | Status: UNKNOWN